title: Adalimumab-induced psoriasis in a patient with Crohn's disease.
authors.forename: Ugur
authors.initials: U
authors.lastname: Korkmaz
authors.forename: Ali Erkan
authors.initials: AE
authors.lastname: Duman
authors.forename: Gokhan
authors.initials: G
authors.lastname: Dindar
authors.forename: Hasan
authors.initials: H
authors.lastname: Yilmaz
authors.forename: Ibrahim Hakki
authors.initials: IH
authors.lastname: Dursun
authors.forename: Altay
authors.initials: A
authors.lastname: Celebi
authors.forename: Omer
authors.initials: O
authors.lastname: Senturk
authors.forename: Sadettin
authors.initials: S
authors.lastname: Hulagu
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006801:Humans; D011565:Psoriasis / Q000139:chemically induced* / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab